deltatrials
Enrolling By Invitation NA INTERVENTIONAL 2-arm NCT06713122

Effects of Symptom Management Education With Mobile Application in Gynecological Cancer Patients Receiving Chemotherapy

The Effect of Symptom Management Training Given to Gynaecological Cancer Patients Receiving Chemotherapy With Artificial Intelligence Supported Mobile Application on Supportive Care Needs, Symptom Severity and Psychological Well-Being

Sponsor: Esra Nur Erdoğan

Conditions Chemotherapy Gynaecological Cancer Nursing Care
Interventions İntervention Group- Group receiving Symptom Management Training with Mobile Application
Updated 2 times since 2025 Last updated: Dec 1, 2024 Started: Jan 1, 2025 Primary completion: Sep 1, 2025 Completion: Feb 2, 2026
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A NA clinical study on Chemotherapy and Gynaecological Cancer, this trial is ongoing. The trial is conducted by Esra Nur Erdoğan and has accumulated 2 data snapshots since 2025. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.

Status Flow

~Jan 2025 – ~Sep 2025 · 8 months · monthly snapshotEnrolling By Invitation~Sep 2025 – present · 12 months · monthly snapshotEnrolling By Invitation

Change History

2 versions recorded

  1. Sep 2025 — Present [monthly]

    Enrolling By Invitation NA

  2. Jan 2025 — Sep 2025 [monthly]

    Enrolling By Invitation NA

    First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Esra Nur Erdoğan
Data source: Saglik Bilimleri Universitesi

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations